AUROBINDO PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 38.6%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 38.6%
Thu, 8 Aug

AUROBINDO PHARMA has announced its results for the quarter ended June 2019. Here is a detailed performance review of the same:

AUROBINDO PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-18*
3
Mar-19*
3
Jun-19*
QoQ ChangeYoY Change
Net SalesRs m42,50352,92254,4462.9%28.1%
Other incomeRs m437323158-51.1%-63.9%
TurnoverRs m42,94053,24554,6042.6%27.2%
ExpensesRs m35,39242,34742,9821.5%21.4%
Gross profitRs m7,11110,21511,33711.0%59.4%
DepreciationRs m1,5451,8662,40929.1%55.9%
InterestRs m295501499-0.4%68.9%
Profit before taxRs m5,7078,1708,5875.1%50.5%
TaxRs m1,1552,3112,278-1.5%97.1%
Profit after taxRs m4,5525,8596,3107.7%38.6%
Gross profit margin%16.719.320.8
Effective tax rate%20.228.326.5
Net profit margin%10.611.011.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 28.1% on a year-on-year (YoY) basis. The expenses were up by 21.4% YoY during the same period.
  • The company's operating profit increased by 59.4% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 20.8% in 1QFY20 as against 16.7% in 1QFY19.
  • Depreciation charges increased by 55.9% and finance costs increased by 68.9% YoY, respectively.
  • Other income declined by 63.9% YoY during the quarter.
  • Net profit for the quarter increased by 38.6% YoY. Net profit margins during the quarter increased from 10.6% in 1QFY19 to 11.6% in 1QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 2.9% on a quarter-on-quarter (QoQ) basis. The expenses were up by 1.5% QoQ during the same period.
  • The company's operating profit increased by 11.0% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 20.8% in 1QFY20 as against 19.3% in 4QFY19.
  • Net profit for the quarter increased by 7.7% QoQ, while net profit margins increased from 11.0% in 4QFY19 to 11.6% in 1QFY20.

To see how AUROBINDO PHARMA has performed over the last eight quarters,please visit here.

AUROBINDO PHARMA Share Price Performance

Over the last one year,AUROBINDO PHARMA share price has moved down from Rs 611.4 to Rs 591.3, registering a Loss of Rs 20.1 or around 3.3%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 12,627.5 (up 0.5%). Over the last one year it has moved down from 14,502.8 to 12,627.5, a gain of 1,875 points (down 12.9%).

Overall, the S&P BSE SENSEX is down 1.4% over the year.

Current Valuations

At the current price of Rs 591.3, the price to earnings (P/E) ratio of AUROBINDO PHARMA stands at 13.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 3.0 times.

Equitymaster requests your view! Post a comment on "AUROBINDO PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 38.6%". Click here!

  

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 4.6% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 4.6% YoY). Sales on the other hand came in at Rs 56 bn (up 17.9% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Nov 6, 2019 | Updated on Nov 6, 2019

Here's an analysis of the annual report of AUROBINDO PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

AUROBINDO PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 10.9% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 10.9% YoY). Sales on the other hand came in at Rs 53 bn (up 30.7% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of AUROBINDO PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Nov 20, 2019 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA - TEVA PHARMA COMPARISON

COMPARE AUROBINDO PHARMA WITH

MARKET STATS